Abstract:A novel group of biocidal compounds are the Crystal 3D (Cry) and Cytolytic (Cyt) proteins produced by Bacillus thuringiensis (Bt). Some Bt Cry proteins have a selective nematocidal activity, with Cry5B being the most studied. Cry5B kills nematode parasites by binding selectively to membrane glycosphingolipids, then forming pores in the cell membranes of the intestine leading to damage. Cry5B selectively targets multiple species of nematodes from different clades and has no effect against mammalian hosts. Levamisole is a cholinergic anthelmintic that acts by selectively opening L-subtype nicotinic acetylcholine receptor ion-channels (L-AChRs) that have been found on muscles of nematodes. A synergistic nematocidal interaction between levamisole and Cry5B at the whole-worm level has been described previously, but the location, mechanism and time-course of this synergism is not known. In this study we follow the timeline of the effects of levamisole and Cry5B on the Ca 2+ levels in enterocyte cells in the intestine of Ascaris suum using fluorescence imaging. The peak Ca 2+ responses to levamisole were observed after approximately 10 minutes while the peak responses to activated Cry5B were observed after approximately 80 minutes. When levamisole and Cry5B were applied simultaneously, we observed that the responses to Cry5B were bigger and occurred sooner than when it was applied by itself. It is proposed that the synergism is due to the cytoplasmic Ca 2+ overload that is induced by the combination of levamisole opening Ca 2+ permeable L-subtype nAChRs and the Ca 2+ permeable Cry5B toxin pores produced in the enterocyte plasma membranes. The effect of levamisole potentiates and speeds the actions of Cry5B that gives rise to bigger Ca 2+ overloads that accelerates cell-death of the enterocytes. The neglected tropical diseases are a diverse set of infectious diseases which are common in low-income populations of Asia, Africa and the Americas. They include soil-transmitted helminth (STH) infections produced by the parasitic nematode Ascaris lumbricoides (= Ascaris suum ). There are no effective vaccines, so mass drug administration ( MDA ) to control and prevent infection is the only practical option. With the limited number of anthelmintic drugs available for treatment, there is an increasing concern about the development of resistance. The use of combinations of anthelmintics, particularly if they are additive, is important for the delay of the onset of resistance. Here we describe synergistic interactions of levamisole and Cry5B mediated by Ca ++ in A . suum intestine enterocytes. We have been able to make these new observations because of our access to A . suum parasites and development of our techniques for studying Ca ++ signaling in the intestine of this nematode parasite, a site of the interaction of these two anthelmintic drugs. Our study provides new insights for development of effective STH combination therapies of anthelmintic drugs for slowing development of resistance with continued mass drug administration and understanding the nematode parasite intestine as a major target for combinations of anthelmintic drugs.

Discovery of a Highly Synergistic Anthelmintic Combination That Shows Mutual Hypersusceptibility

In Vivo and in Vitro Studies of Cry5B and Nicotinic Acetylcholine Receptor Agonist Anthelmintics Reveal a Powerful and Unique Combination Therapy Against Intestinal Nematode Parasites

First Optimal Drug Combination for Roundworms

Mechanistic and Single-Dose in Vivo Therapeutic Studies of Cry5B Anthelmintic Action Against Hookworms.

An Extensive Comparison of the Effect of Anthelmintic Classes on Diverse Nematodes

The New Anthelmintic Tribendimidine is an L-type (levamisole and Pyrantel) Nicotinic Acetylcholine Receptor Agonist

Nitazoxanide: nematicidal mode of action and drug combination studies.

Bacillus Subtilis Strain Engineered for Treatment of Soil-Transmitted Helminth Diseases

Promise of Bacillus Thuringiensis Crystal Proteins As Anthelmintics

Bacillus Thuringiensis Cry5B Protein is Highly Efficacious As a Single-Dose Therapy Against an Intestinal Roundworm Infection In

Bacterial Pore-Forming Proteins As Anthelmintics.

Bacillus Thuringiensis Cry5B Protein As a New Pan-Hookworm Cure

Three Small Molecule Entities (MPK18, MPK334 and YAK308) with Activity against Haemonchus contortus In Vitro

The nematode ( Ascaris suum ) intestine is a location of synergistic anthelmintic effects of Cry5B and levamisole

Bacillus Thuringiensis-Derived Cry5B Has Potent Anthelmintic Activity Against Ascaris Suum.

An Inactivated Bacterium (paraprobiotic) Expressing Bacillus Thuringiensis Cry5B As a Therapeutic for Ascaris and Parascaris Spp. Infections in Large Animals.

Bacillus Thuringiensis Cry5B is Active Against Strongyloides Stercoralis in Vitro.

Effective drug combination for Caenorhabditis elegans nematodes discovered by output-driven feedback system control technique

Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity

Broad-Spectrum Inhibitors for Conserved Unique Phosphoethanolamine Methyltransferases in Parasitic Nematodes Possess Anthelmintic Efficacy

Efficacy of Anthelminthic Drugs and Drug Combinations Against Soil-transmitted Helminths: A Systematic Review and Network Meta-analysis